ABO Blood Type Incompatibility Is Not a Risk Factor of Outcomes for Acute Myeloid Leukemia (AML) Patients After Unmanipulated Haplo-identical Peripheral Blood Hematopoietic Stem Cell Transplantation.

CONCLUSIONS This study demonstrated ABO incompatibility is not an independent risk factor of outcomes for AML patients who received unmanipulated haplo-identical peripheral blood HSCT. ABO compatibility might have limited value in haplo-identical donor selection.
PMID: 31197126 [PubMed - in process]

Source: Annals of Transplantation - June 13, 2019 Category: Transplant Surgery Authors: Yang N, Guan L, Liu Z, Ding Y, Zhu C, Luo L, Wang F, Fang S, Gao Z, Gu Z, Gao C Tags: Ann Transplant Source Type: research